Abstract：Bronchopulmonary dysplasia (BPD) has the main manifestations of pulmonary edema in the early stage and characteristic alveolar obstruction and microvascular dysplasia in the late stage, which may be caused by structural and functional destruction of the lung epithelial barrier. The Claudin family is the main component of tight junction and plays an important role in regulating the permeability of paracellular ions and solutes. Claudin-18 is the only known tight junction protein solely expressed in the lung. The lack of Claudin-18 can lead to barrier dysfunction and impaired alveolar development, and the knockout of Claudin-18 can cause characteristic histopathological changes of BPD. This article elaborates on the important role of Claudin-18 in the development and progression of BPD from the aspects of lung epithelial permeability, alveolar development, and progenitor cell homeostasis, so as to provide new ideas for the pathogenesis and clinical treatment of BPD.
ZUO Jing-Ye,TONG Ya-Jie,YUE Dong-Mei. A review on the effect of Claudin-18 on bronchopulmonary dysplasia in preterm infants[J]. CJCP, 2021, 23(5): 542-547.
Claesson-Welsh L, Dejana E, McDonald DM. Permeability of the endothelial barrier:identifying and reconciling controversies[J]. Trends Mol Med, 2020. DOI:10.1016/j.molmed.2020.11.006. Epub ahead of print.
[5]
Musante I, Scudieri P, Venturini A, et al. Peripheral localization of the epithelial sodium channel in the apical membrane of bronchial epithelial cells[J]. Exp Physiol, 2019, 104(6):866-875.
[6]
Hagen SJ. Non-canonical functions of claudin proteins:beyond the regulation of cell-cell adhesions[J]. Tissue Barriers, 2017, 5(2):e1327839.
[7]
Krause G, Protze J, Piontek J. Assembly and function of claudins:structure-function relationships based on homology models and crystal structures[J]. Semin Cell Dev Biol, 2015, 42:3-12.
[8]
Milatz S, Breiderhoff T. One gene, two paracellular ion channels-claudin-10 in the kidney[J]. Pflugers Arch, 2017, 469(1):115-121.
[9]
Rahman MT, Ghosh C, Hossain M, et al. IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers:relevance for neuro-inflammatory diseases[J]. Biochem Biophys Res Commun, 2018, 507(1-4):274-279.
[10]
Berndt P, Winkler L, Cording J, et al. Tight junction proteins at the blood-brain barrier:far more than claudin-5[J]. Cell Mol Life Sci, 2019, 76(10):1987-2002.
[11]
Suzuki H, Nishizawa T, Tani K, et al. Crystal structure of a claudin provides insight into the architecture of tight junctions[J]. Science, 2014, 344(6181):304-307.
[12]
Piontek J, Krug SM, Protze J, et al. Molecular architecture and assembly of the tight junction backbone[J]. Biochim Biophys Acta Biomembr, 2020, 1862(7):183279.
[13]
Hashimoto Y, Yagi K, Kondoh M. Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers[J]. Pflugers Arch, 2017, 469(1):45-53.
[14]
Suzuki H, Tani K, Tamura A, et al. Model for the architecture of claudin-based paracellular ion channels through tight junctions[J]. J Mol Biol, 2015, 427(2):291-297.
[15]
Tsukita S, Tanaka H, Tamura A. The claudins:from tight junctions to biological systems[J]. Trends Biochem Sci, 2019, 44(2):141-152.
[16]
Krause G, Winkler L, Mueller SL, et al. Structure and function of claudins[J]. Biochim Biophys Acta, 2008, 1778(3):631-645.
[17]
Schlingmann B, Molina SA, Koval M. Claudins:gatekeepers of lung epithelial function[J]. Semin Cell Dev Biol, 2015, 42:47-57.
[18]
Günzel D, Yu AS. Claudins and the modulation of tight junction permeability[J]. Physiol Rev, 2013, 93(2):525-569.
[19]
Koval M. Claudin heterogeneity and control of lung tight junctions[J]. Annu Rev Physiol, 2013, 75:551-567.
[20]
Lynn KS, Peterson RJ, Koval M. Ruffles and spikes:control of tight junction morphology and permeability by claudins[J]. Biochim Biophys Acta Biomembr, 2020, 1862(9):183339.
LaFemina MJ, Rokkam D, Chandrasena A, et al. Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells[J]. Am J Physiol Lung Cell Mol Physiol, 2010, 299(6):L724-L734.
[23]
Türeci O, Koslowski M, Helftenbein G, et al. Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals[J]. Gene, 2011, 481(2):83-92.
[24]
LaFemina MJ, Sutherland KM, Bentley T, et al. Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice[J]. Am J Respir Cell Mol Biol, 2014, 51(4):550-558.
[25]
Lewis JB, Jimenez FR, Merrell BJ, et al. The expression profile of claudin family members in the developing mouse lung and expression alterations resulting from exposure to secondhand smoke (SHS)[J]. Exp Lung Res, 2018, 44(1):13-24.
[26]
Weber B, Mendler MR, Lackner I, et al. Lung injury after asphyxia and hemorrhagic shock in newborn piglets:analysis of structural and inflammatory changes[J]. PLoS One, 2019, 14(7):e0219211.
[27]
Titto M, Ankit T, Saumya B, et al. Curcumin prophylaxis refurbishes alveolar epithelial barrier integrity and alveolar fluid clearance under hypoxia[J]. Respir Physiol Neurobiol, 2020, 274:103336.
[28]
Reynolds CJ, Quigley K, Cheng XM, et al. Lung defense through IL-8 carries a cost of chronic lung remodeling and impaired function[J]. Am J Respir Cell Mol Biol, 2018, 59(5):557-571.
[29]
Lee PH, Hong JS, Jang AS. N-acetylcysteine decreases airway inflammation and responsiveness in asthma by modulating claudin 18 expression[J]. Korean J Intern Med, 2020, 35(5):1229-1237.
[30]
Imtiazul IM, Asma R, Lee JH, et al. Change of surfactant protein D and A after renal ischemia reperfusion injury[J]. PLoS One, 2019, 14(12):e0227097.
[31]
Jin WT, Rong LY, Liu YK, et al. Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury[J]. Respirology, 2013, 18(4):643-651.
[32]
Abdul-Hafez A, Mohamed T, Uhal BD. Activation of mas restores hyperoxia-induced loss of lung epithelial barrier function through inhibition of apoptosis[J]. J Lung Pulm Respir Res, 2019, 6(3):58-62.
[33]
Shimobaba S, Taga S, Akizuki R, et al. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells[J]. Biochim Biophys Acta, 2016, 1863(6 Pt A):1170-1178.
[34]
Schlingmann B, Overgaard CE, Molina SA, et al. Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions[J]. Nat Commun, 2016, 7:12276.
[35]
Bazzoni G, Tonetti P, Manzi L, et al. Expression of junctional adhesion molecule-A prevents spontaneous and random motility[J]. J Cell Sci, 2005, 118(Pt 3):623-632.
[36]
Mitchell LA, Ward C, Kwon M, et al. Junctional adhesion molecule A promotes epithelial tight junction assembly to augment lung barrier function[J]. Am J Pathol, 2015, 185(2):372-386.
[37]
Barth K, Bläsche R, Neißer A, et al. P2X7R-dependent regulation of glycogen synthase kinase 3β and claudin-18 in alveolar epithelial type I cells of mice lung[J]. Histochem Cell Biol, 2016, 146(6):757-768.
[38]
Sucre JMS, Jetter CS, Loomans H, et al. Successful establishment of primary type II alveolar epithelium with 3D organotypic coculture[J]. Am J Respir Cell Mol Biol, 2018, 59(2):158-166.
[39]
Shi F, Liao Y, Dong YZ, et al. Claudin18 associated with corticosteroid-induced expression of surfactant proteins in pulmonary epithelial cells[J]. J Matern Fetal Neonatal Med, 2019, 32(5):809-814.
[40]
Niimi T, Nagashima K, Ward JM, et al. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung-and stomach-specific isoforms through alternative splicing[J]. Mol Cell Biol, 2001, 21(21):7380-7390.
[41]
Li GL, Flodby P, Luo J, et al. Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis[J]. Am J Respir Cell Mol Biol, 2014, 51(2):210-222.
[42]
Day CL, Ryan RM. Bronchopulmonary dysplasia:new becomes old again![J]. Pediatr Res, 2017, 81(1-2):210-213.
[43]
Hagen SJ, Ang LH, Zheng Y, et al. Loss of tight junction protein claudin 18 promotes progressive neoplasia development in mouse stomach[J]. Gastroenterology, 2018, 155(6):1852-1867.
Luo J, Chimge NO, Zhou BY, et al. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro[J]. Int J Cancer, 2018, 143(12):3169-3180.
[46]
Zhou BY, Flodby P, Luo J, et al. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis[J]. J Clin Invest, 2018, 128(3):970-984.
[47]
Kage H, Flodby P, Zhou BY, et al. Dichotomous roles of claudins as tumor promoters or suppressors:lessons from knockout mice[J]. Cell Mol Life Sci, 2019, 76(23):4663-4672.
[48]
van Soldt BJ, Qian J, Li J, et al. Yap and its subcellular localization have distinct compartment-specific roles in the developing lung[J]. Development, 2019, 146(9):dev175810.
